Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome
Clinical trial NCT03081598 · TERMINATED
Trial details
- NCT number
- NCT03081598
- Sponsor
- Liminal BioSciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-29
- Primary completion
- 2018-09-06
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.